SPARC, Schrodinger collaborate to accelerate discovery of novel CNS therapeutics

03 Dec 2018 Evaluate

Sun Pharma Advanced Research Company (SPARC) and Schrodinger have entered into a research collaboration to accelerate the discovery of novel CNS therapeutics by leveraging Schrodinger's advanced computational platform and SPARC's extensive drug development expertise and insights in neurodegeneration.

Schrodinger, a privately held company committed to revolutionizing drug discovery through advanced molecular simulation, will focus on lead discovery and optimization.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

134.90 0.45 (0.33%)
31-Dec-2025 10:07 View Price Chart
Peers
Company Name CMP
Syngene Internation. 642.00
Indegene 521.00
CMS Info Systems 339.65
Sagility 52.63
Smartworks Coworking 472.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×